Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

CENTOGENE Extends Strategic Partnership with Takeda

Tuesday, April 11, 2023

CENTOGENE announced it has extended its partnership with Takeda to diagnose patients with Lysosomal Storage Disorders LSDs Under the renewed oneyear partnership agreement CENTOGENE will continue to provide Takeda with access to diagnostic testing for...

Panbela Announces Regain of Worldwide Rights to Develop and Commercialise FlynpoviTM

Tuesday, April 11, 2023

Panbela Therapeutics announced that it has regained the North American rights to develop and commercialise Flynpovi the combination of CPPX eflornithine and sulindac in patients with familial adenomatous polyposis FAP The new FAP registration trial w...

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab

Tuesday, April 11, 2023

Shanghai Junshi Biosciences announced the acceptance of the supplemental new drug application for toripalimab in combination with chemotherapy as perioperative treatment and toripalimab monotherapy as consolidation therapy after adjuvant therapy for...

Cognisant Collaborates with Boehringer Ingelheim

Tuesday, April 11, 2023

Cognisant announced that it is working with Boehringer Ingelheim to advance the speed and quality of medicinal therapy development Leveraging the Veeva Development Cloud Cognisant will help Boehringer Ingelheim to unify medicinal development processe...

CiRA, Kyoto University and Astellas Pharma Enter into Joint Research Agreement

Tuesday, April 11, 2023

The Centre for iPS Cell Research and Application Kyoto University and Astellas Pharma entered into the second phase of a joint research agreement to further promote the utilization of differentiated cells and tissues derived from human induced plurip...

Ultima Genomics Collaborates with Genome Insight

Monday, April 10, 2023

Ultima Genomics and Genome Insight have signed an agreement to collaborate to bring affordable whole genome sequencing solutions to cancer patients As part of the agreement Genome Insight will join the early access programme for Ultimas highthroughpu...

Sumitomo Pharma Oncology Receives Orphan Drug Designation for TP-1287

Monday, April 10, 2023

Sumitomo Pharma Oncology announced the US Food and Drug Administration FDA granted Orphan Drug Designation for TP an investigational oral CDK inhibitor for the treatment of Ewing sarcoma TP exhibits potent inhibition of intracellular kinases includin...

Biotheryx Announces Research Collaboration and Licence Agreement with Incyte

Thursday, April 06, 2023

Biotheryx announced it has entered into a Research Collaboration and Licence agreement with Incyte to discover and develop targeted protein degraders for novel oncology targets Under the terms of the agreement Biotheryx will utilise its distinctive P...

RespireRx Pharmaceuticals Announces Collaboration with University College London (UCL)

Thursday, April 06, 2023

RespireRx Pharmaceuticals announced that it has entered into a material transfer agreement with University College London UCL As part of the collaboration the RespireRx research team will be working to study the possibility of using CX RespireRxs lea...

InflaRx Announces FDA Emergency Use Authorisation for Gohibic (vilobelimab)

Wednesday, April 05, 2023

InflaRx announced that Gohibic vilobelimab a firstinclass monoclonal antihuman complement factor Ca antibody has been granted an Emergency Use Authorisation EUA by the US Food and Drug Administration FDA for the treatment of coronavirus disease COVI...